Recursion Pharmaceuticals Inc (NASDAQ:RXRX) price closed lower on Friday, June 27, and dropping -6.85% below its previous close. A look at the daily price movement shows that the last close reads $5.4, with intraday deals fluctuated between $4.98 and $5.48. The company’s 5Y monthly beta
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) concluded the trading at $5.16 on Wednesday, June 25 with a fall of -1.15% from its closing price on previous day. Considering stock’s 52-week price range provides that RXRX hit a high price of $12.36 and saw its price falling to
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded at $5.11 at close of the session on Friday, June 20 and made an upward move of 5.03% on its previous day’s price. Looking at the stock we see that its previous close was $6.67 and the beta (5Y monthly)
The trading price of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) closed lower on Tuesday, June 17, and closing at $4.84, -3.20% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $12.36 and a 52-week low
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) price on Thursday, June 12, fall -4.26% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $5.17. A look at the stock’s price movement, the close in the last trading session was $5.40. Turning
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) price closed lower on Monday, June 09, and dropping -2.19% below its previous close. A look at the daily price movement shows that the last close reads $5.49. Taking into account the 52-week price action we note that the stock hit
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) concluded the trading at $4.91 on Wednesday, June 04 with a rise of 11.85% from its closing price on previous day. Considering stock’s 52-week price range provides that RXRX hit a high price of $12.36 and saw its price falling to
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded at $4.18 at close of the session on Friday, May 30 and made a downward move of -6.07% on its previous day’s price. Recursion Pharmaceuticals Inc has a market cap of $1.70 billion and is expected to release its quarterly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.